Engineering an Insulin Complex to Treat Diabetes

A subcutaneously injected glucose-responsive insulin was tested for efficacy on blood glucose levels in animal models of type 1 diabetes but may also help persons with type 2 diabetes receiving insulin therapy.

​   The New England Journal of Medicine: Search Results in Endocrinology